Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
CC transcript

IMCLONE SYSTEMS INC (IMCL) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/09/2008 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/26/2008 8-K Quarterly results
11/26/2008 4 ZUERBLIS KENNETH J (SVP & CFO) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 80,000 options to buy @ $42.42, valued at $3.4M
11/26/2008 4 WITTE LARRY (SVP, Research) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 3,000 restricted stock units @ $0
Disposed/sold 36,000 options to buy @ $36.7, valued at $1.3M
11/26/2008 4 Schloss David (VP, Human Resources) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 1,000 restricted stock units @ $0
Disposed/sold 36,000 options to buy @ $31.15, valued at $1.1M
11/26/2008 4 Rowinsky Eric K (SVP, Chief Medical Officer) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 31,333 restricted stock units @ $0
Disposed/sold 75,000 options to buy @ $42.52, valued at $3.2M
Disposed/sold 25,000 options to buy @ $34.14, valued at $853.5k
11/26/2008 4 Powell Andrew Kenneth William (SVP, General Counsel) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 60,000 options to buy @ $64.09, valued at $3.8M
11/26/2008 4 Johnson John H (CEO) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 23,610 restricted stock units @ $0
Disposed/sold 350,000 options to buy @ $31.9, valued at $11.2M
11/26/2008 4 DePinto Joseph I (VP, Commercial Ops) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 45,000 options to buy @ $40.09, valued at $1.8M
11/26/2008 4 Ehmer Bernhard (SVP & Managing Dir., Int'l Ops) has filed a Form 4 on IMCLONE SYSTEMS INC
Txns: Disposed/sold 60,000 options to buy @ $43.58, valued at $2.6M
11/26/2008 4 Form 4 - Statement of changes in beneficial ownership of securities
11/24/2008 SC 13D/A Carl Icahn reports a 0% stake in ImClone Systems Incorporated
11/21/2008 SC 13D/A LILLY ELI & CO has filed a Schedule 13D for IMCLONE SYSTEMS INCORPORATED
11/10/2008 10-Q Quarterly Report for the period ended September 30, 2008
11/05/2008 SC 13G/A Clearbridge Advisors, LLC reports a 0% stake in ImClone Systems Inc Address of issuers principal executive offices: 180 Varick Street 6th Floor New York, NY 10014 United States Item 2a) Name of person filing: ClearBridge Advisors, LLC Item 2b) Address of principal business office: 620 8th Avenue New York, NY 10018 Item 2c) Citizenship: ClearBridge Advisors, LLC Delaware Limited Liability Corporation Item 2d)
11/04/2008 8-K Form 8-K -- Current report
10/16/2008 SC 13D LILLY ELI & CO has filed a Schedule 13D for IMCLONE SYSTEMS INCORPORATED
10/08/2008 SC 13D/A Carl Icahn has filed a Schedule 13D for ImClone Systems Incorporated
10/08/2008 SC 13D/A BRISTOL MYERS SQUIBB CO reports a 16.6% stake in ImClone Systems Incorporated
10/08/2008 8-K Form 8-K -- Current report
10/07/2008 SC 13D/A Carl Icahn reports a 13.4% stake in ImClone Systems Incorporated
10/02/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "IMCLONE SYSTEMS ISSUES STATEMENT"
09/29/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "IMCLONE SYSTEMS ISSUES STATEMENT"
09/26/2008 8-K Other Events
09/25/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
09/23/2008 SC 13D/A BRISTOL MYERS SQUIBB CO reports a 16.6% stake in ImClone Systems Incorporated
09/16/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
09/12/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "IMCLONE SYSTEMS SUBMITS LETTER TO BRISTOL-MYERS SQUIBB"
09/12/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "IMCLONE SYSTEMS ISSUES STATEMENT"
09/04/2008 8-K Other Events
09/02/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "ERBITUX ® PHASE 3 BMS-099 LUNG CANCER STUDY SECONDARY ENDPOINT UPDATE: OVERALL SURVIVAL RESULTS ANNOUNCED"
08/11/2008 8-K Other Events
08/08/2008 10-Q Quarterly Report for the period ended June 30, 2008
08/07/2008 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy